Drug Profile
Interleukin-1-beta - Sclavo
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Sclavo
- Class Antineoplastics; Immunotherapies; Interleukins
- Mechanism of Action Interleukin-1beta replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 Nov 1995 Discontinued-Preclinical for Cancer in Italy (Unknown route)